Gut dysbiosis-mediated platelet activation as MASLD and cardiovascular disease link
Trends in Endocrinology & Metabolism · 2026-06 · 37 (6) · 490-492
DOI: 10.1016/j.tem.2026.02.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Endocrinology & Metabolism, 2026-06. Verfasst von Francesco Violi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Sapienza University of Rome, Latina, Italy. Electronic address: francesco.violi@uniroma1.it. Hauptthemen laut MEDLINE: Platelet Activation, Cardiovascular Diseases, Dysbiosis, Gastrointestinal Microbiome. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sapienza University of Rome, Latina, Italy. Electronic address: francesco.violi@uniroma1.it.
- Department of Medical and Cardiovascular Sciences, Sapienza University of Rome, Latina, Italy. Electronic address: pasquale.pignatelli@uniroma1.it.
- Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.
- Department of Medical and Cardiovascular Sciences, Sapienza University of Rome, Latina, Italy.
Zitieren
APA
Violi, F., Pignatelli, P., Carnevale, R., & Bartimoccia, S. (2026). Gut dysbiosis-mediated platelet activation as MASLD and cardiovascular disease link. Trends in Endocrinology & Metabolism, 37(6), 490-492. https://doi.org/10.1016/j.tem.2026.02.003
Vancouver
Violi F, Pignatelli P, Carnevale R, Bartimoccia S. Gut dysbiosis-mediated platelet activation as MASLD and cardiovascular disease link. Trends in Endocrinology & Metabolism. 2026;37(6):490-492. doi:10.1016/j.tem.2026.02.003
BibTeX
@article{Violi2026,
author = {Violi, Francesco and Pignatelli, Pasquale and Carnevale, Roberto and Bartimoccia, Simona},
title = {Gut dysbiosis-mediated platelet activation as MASLD and cardiovascular disease link},
journal = {Trends in Endocrinology & Metabolism},
year = {2026},
volume = {37},
number = {6},
pages = {490--492},
doi = {10.1016/j.tem.2026.02.003}
}
EUVIMED